LVW Advisors’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-946
Closed -$253K – 466
2026
Q2
$253K Sell
946
-79
-8% -$18.5K 0.02% 386
2026
Q1
$234K Sell
1,025
-140
-12% -$31.4K 0.02% 381
2025
Q4
$248K Buy
1,165
+8
+0.7% +$1.65K 0.03% 308
2025
Q3
$230K Sell
1,157
-11
-0.9% -$2.05K 0.02% 320
2025
Q2
$202K Buy
+1,168
New +$190K 0.02% 321

Other funds holding ASND

LVW Advisors's ASND Position: Q3 2026 in Review

LVW Advisors sold out of Ascendis Pharma (ASND) in Q3 2026, closing a stake of 946 shares — an estimated $253K sold.

LVW Advisors first reported a position in ASND in Q2 2025 and held it in 5 quarters. The position peaked at $253K in Q2 2026. 347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • LVW Advisors reported no remaining Ascendis Pharma position as of Q3 2026 after selling out during the quarter.
  • LVW Advisors sold 946 Ascendis Pharma shares in Q3 2026, an estimated $253K.
  • LVW Advisors first reported a position in Ascendis Pharma in Q2 2025 and held it in 5 quarters.
  • LVW Advisors's Ascendis Pharma position peaked at $253K in Q2 2026.
  • 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.

Based on LVW Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.